Address
9841 Washingtonian Blvd, Suite 200 Gaithersburg, MD 20878, USA
Situation
Regulatory organizations manage large volumes of adverse event (AE) data across multiple programs, products, and operational centers. Ensuring that this information is collected, processed, and analyzed consistently is essential for maintaining effective pharmacovigilance and regulatory oversight.
To strengthen safety monitoring capabilities and improve operational consistency, FDA Centers selected Aris Global LifeSphere MultiVigilance (LSMV) as the enterprise platform for managing adverse event data across products and centers. The initiative aimed to establish a standardized system that could support diverse regulatory workflows while enabling consistent data governance across the organization.
Successfully implementing such a platform required aligning multiple stakeholders, harmonizing requirements across centers, and ensuring that the platform could support both enterprise goals and operational needs.
Challenge
Adopting an enterprise-wide safety platform introduced several complexities that needed to be carefully addressed.
Each FDA Center had developed its own workflows, reporting structures, and data requirements over time. Bringing these varied approaches together within a single platform required balancing standardization with operational flexibility.
Key challenges included:
- Reconciling center-specific workflows and reporting requirements within a unified platform structure.
- Ensuring that regulatory and operational needs were fully reflected in the system configuration.
- Minimizing disruption to ongoing safety and regulatory operations during platform adoption.
- Reducing the risk of excessive customization that could impact the platform’s long-term sustainability.
Addressing these challenges required a collaborative approach that could translate complex regulatory and operational requirements into a scalable enterprise solution.
Solution
Cognizance Technologies worked closely with the Aris Global LifeSphere MultiVigilance team and cross-center stakeholders to support the successful adoption of the platform.
Our approach focused on enabling enterprise alignment while preserving the operational integrity of individual centers. Key activities included:
- Stakeholder engagement and requirement harmonizationCollaborated with representatives from multiple FDA Centers to identify, reconcile, and align requirements across programs.
- Platform alignment and configuration guidanceMapped regulatory and operational needs to the core capabilities of the LSMV platform, helping ensure the system could support essential workflows while maintaining platform integrity.
- Enterprise framework developmentEstablished a standardized approach to data elements, reporting structures, and safety workflows to support consistent adverse event management across centers.
- Strategic enablement for long-term adoptionWorked alongside program stakeholders to position LSMV as a sustainable enterprise platform capable of supporting future regulatory and safety operations.
Rather than focusing solely on technical implementation, our role emphasized bridging regulatory requirements, operational processes, and platform capabilities to support effective system adoption.
Results
Through this collaborative effort, FDA stakeholders were able to establish a stronger foundation for enterprise-level adverse event data management. The initiative enabled:
- A standardized enterprise platform for adverse event data collection and management.
- Improved alignment between regulatory processes and system capabilities.
- Reduced transition risks through structured stakeholder collaboration and requirement harmonization.
- A scalable framework that supports consistent safety monitoring and reporting across centers.
By aligning enterprise objectives with the capabilities of the LifeSphere MultiVigilance platform, the engagement helped reinforce the role of LSMV as a foundational system for regulatory safety operations, supporting long-term efficiency, transparency, and data integrity.